At sixteen, while many teenagers were occupied with spending money, Tyler Stafford opened a Roth IRA. Stock investments had caught his attention in high school, and compounding apparently seemed more interesting than whatever else was competing for a Memphis teenager's cash. It is a small detail, almost comically on-brand in retrospect. Stafford would spend his career studying what money does, how institutions decide where it goes, and what happens when their formulas fail to see the person standing in front of them.
That curiosity took him from a management degree at Harding University into the training program at Regions Financial. He learned banking from the inside, then focused on credit analysis and commercial underwriting. At night and between working hours, he completed a master's in finance at the University of Memphis. In 2011 he joined Stephens Inc. in Little Rock as a research associate covering regional banks.
The work rewarded disciplined skepticism. An equity analyst cannot be seduced by a handsome lobby or a confident quarterly call. He has to inspect the loan book, test the assumptions and ask whether a bank understands its own risks. Stafford advanced through analyst roles to managing director, advising institutional investors on bank performance and valuation. In 2017, Institutional Investor named him an All-America Research Team Rising Star. He had become fluent in the peculiar grammar of banks.
Then the grammar met a sentence it could not parse
Michael Jerkins and Ned Palmer were doctors with a recurring complaint. Early-career doctors could carry substantial education debt, earn relatively little during training and have thin credit files. Conventional underwriting often read those facts as weakness. It paid less attention to the delayed but relatively legible earnings path ahead. Jerkins and Palmer had experienced the mismatch and heard versions of it from other doctors.
For Stafford, the problem arrived through an unusually old connection. He and Jerkins had known each other since ninth grade and later roomed together at Harding. The two doctors understood the customer because they had lived the customer's financial life. Stafford understood why the bank's machinery produced the answer it did. Friendship supplied the introduction; complementary expertise supplied the company.
The doctors had already tried taking their idea to traditional banks. The reception was discouraging. When Stafford joined, he recognized both the customer problem and a strategic opening. Most banks sold broadly similar products to broadly defined customers. A platform built for one profession could design around the entire career instead: school, training, a first contract, practice ownership and eventually retirement.
Stafford left Stephens and became Panacea's CEO. The team found a bank partner in Primis, whose platform allowed the new venture to operate nationally. Panacea made its first loan in November 2020. The founding thesis was precise: doctors should not be judged as generic borrowers when their careers follow a distinct financial arc.
The analyst learns to make the call
Founding tested a different set of muscles. Research favors a careful accumulation of evidence. Operating often presents a clock, incomplete information and several choices that are each slightly wrong. Stafford says learning to trust his intuition became one of his important leadership lessons. Some of his larger regrets, he has said, came when an instinct warned him and he ignored it.
His formula is not romantic. Gather the information available, trust your intuition and decide. It is the analyst's respect for evidence with the operator's acceptance that evidence will sometimes arrive late. The distinction matters in finance, where speed never excuses care and care can become an elegant excuse for standing still.
Panacea's leadership meetings reflect that impatience with ceremony. Each leader prepares four categories before the weekly session: information everyone should know, blockers that need resolution, decisions the group must make, and collaboration required from colleagues. Material that can simply be read is read in advance. The room is reserved for debate, problem-solving and action.
It is an admirably severe design for a meeting. Status updates are the office equivalent of clearing one's throat: sometimes necessary, rarely the reason anybody came. Stafford describes Panacea as a low-ego organization where the soundest idea can win. The prepared framework gives that aspiration some machinery. Ideas get a fairer hearing when everyone knows which question the room is supposed to answer.
Mow your own grass
The more memorable piece of Stafford's operating philosophy involves an actual lawn. Until roughly 2025, he says, he mowed the grass at Panacea's office on weekends to save a little money. He readily admits the financial effect was trivial. The gesture mattered because it made a view of leadership visible: no useful job is beneath the person with the grandest title.
Founders are fond of metaphors and lawns are helpfully resistant to PowerPoint. They grow. Someone has to notice. Someone has to do the work. Stafford turned the chore into a phrase, “mow your own grass,” meaning leaders should do small things, get their hands dirty and establish the standard through conduct. It is not a proposal that CEOs everywhere seize the landscaping budget. It is a reminder that culture pays close attention to what leaders refuse to touch.
His approach to hiring runs in the opposite direction from penny-pinching. Panacea invested early in experienced people instead of assembling a cheaper junior team. Stafford argues that seasoned specialists reduced mistakes and distraction, protected the culture and helped the business move faster. He reported less than 2 percent cumulative voluntary attrition over the company's first five years. The lawn might save a few dollars. The talent line was not where he wanted to economize.
A narrow customer, a wider system
By July 2025, Valar Ventures had added $37 million to Panacea's Series B, bringing the round to $62 million. The company said it had processed more than $2 billion in loan applications and was expanding an integrated platform across lending, banking, legal and advisory work. In 2026, Stafford announced another marker: Panacea had crossed $1 billion in funded loans to doctors and their practices.
The numbers are evidence of scale, but the strategy remains rooted in specificity. Stafford calls the ambition a “financial operating system for doctors.” The phrase can sound like software invading a bank branch, but its meaning is practical. A resident financing a move, a dentist buying a practice and a veterinarian planning a partner buyout may look unrelated to a generalist institution. Within one professional arc, they are consecutive chapters.
Stafford now sees data and artificial intelligence extending that logic. A generic financial app knows transactions. A vertical platform can also understand the contours of a career, the timing of training, the economics of practice ownership and the decisions likely to arrive next. His stated goal is to combine those patterns with financial data to produce more useful guidance. The opportunity is personalization; the obligation, in a regulated business, is disciplined risk control.
Here the old equity analyst remains visible. Panacea uses a three-lines-of-defense approach: business teams own the controls in their work, an independent compliance and risk function monitors them, and audit or external review tests the system. Stafford's version of innovation is less a wild leap than a well-inspected bridge. Move quickly, certainly. Also check the bolts.
The fixed point
Stafford separates a company's mission from its route. Markets change, roadblocks appear and products evolve. He believes the route must remain flexible while the mission stays fixed. At Panacea, the fixed point is improving doctors' financial lives. That framing has allowed the company to move beyond its earliest personal-loan products without losing the reason those products existed.
It also extends to the Panacea Financial Foundation, which provides scholarships and grants to medical students, residents and fellows from underrepresented backgrounds. Stafford has said the foundation had provided more than $250,000 by 2026. His aspiration is to widen access to professional education while building financing that accounts for a student's future career rather than treating current means as the whole story.
There is a tidy symmetry in Stafford's career. At sixteen, he placed a bet on a future self by opening that Roth IRA. Years later, he helped build a company around the idea that financial institutions should become better at recognizing future selves too. A doctor in training is not only today's income, today's debt or today's thin credit file. The future does not belong on a balance sheet as wishful thinking. Sometimes, however, refusing to model it is the less accurate choice.
The stealable lesson is narrower than “find a niche” and more useful: combine the customer's lived truth with fluency in the system that keeps disappointing them. Then design the operating habits that let the insight survive growth. For Stafford, those habits include prepared meetings, experienced hires, informed instinct and the occasional encounter with a lawn mower. Finance likes abstractions. Building remains stubbornly physical.